Dombret, H., & Itzykson, R. (2017). How and when to decide between epigenetic therapy and chemotherapy in patients with AML. Hematology Am Soc Hematol Educ Program.
Chicago-стиль цитированияDombret, Hervé, and Raphael Itzykson. "How and When to Decide between Epigenetic Therapy and Chemotherapy in Patients With AML." Hematology Am Soc Hematol Educ Program 2017.
MLA-цитированиеDombret, Hervé, and Raphael Itzykson. "How and When to Decide between Epigenetic Therapy and Chemotherapy in Patients With AML." Hematology Am Soc Hematol Educ Program 2017.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.